Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Ginkgo Bioworks Hldgs Inc (NY: DNA )

0.7984 -0.0474 (-5.60%)
Streaming Delayed Price Updated: 10:22 AM EDT, Apr 25, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 9,184,250
Open 0.8210
Bid (Size) 0.7983 (5)
Ask (Size) 0.7984 (11)
Prev. Close 0.8458
Today's Range 0.7863 - 0.8210
52wk Range 0.8100 - 2.545
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Novo Nordisk and Ginkgo Bioworks Are Teaming Up. Here's Why That's Bullish for Both Stocks.
The collaboration could help solve challenges for both businesses. 
Via The Motley Fool
What's Going On With Ginkgo Bioworks Stock?
Ginkgo Bioworks announced the expansion of its strategic partnership with Novo Nordisk A/S on Wednesday under a framework agreement that initially is contemplated to run over five years.Ginkgo said the... 
Via Benzinga

Performance

YTD
-52.19%
-52.19%
1 Month
-26.75%
-26.75%
3 Month
-35.61%
-35.61%
6 Month
-44.56%
-44.56%
1 Year
-34.02%
-34.02%

More News

Read More
Bull Market and Beyond: 3 Stocks Just Waiting to Soar
Via The Motley Fool
The AI Advantage: 2 Healthcare Stocks at the Forefront of Innovation
Via The Motley Fool
Topics Artificial Intelligence
Exposures Artificial Intelligence
2 Stocks That Could More Than Double Your Money, According to Wall Street: Are They Buys Now?
Via The Motley Fool
Is Ginkgo Bioworks Stock a Buy?
Via The Motley Fool
Why Ginkgo Bioworks Stock Is Sinking Today
Via The Motley Fool
Earnings Scheduled For February 29, 2024
Via Benzinga
Earnings Outlook For Ginkgo Bioworks Holdings
Via Benzinga
Why Kodiak Sciences Shares Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
Dyadic Intl. Inc. (NASDAQ: DYAI) Potential Strategic Alliances with Future of Foods Boosts Stock as Key Conference Looms
Via AB Newswire
Topics Supply Chain
Exposures Supply Chain
3 Pharmaceutical Stocks to Buy Hand Over Fist in March
Via The Motley Fool
Is Ginkgo Bioworks Stock a Buy Now?
Via The Motley Fool
Is Ginkgo Bioworks Destined to Be in a "Magnificent Seven" of Healthcare Stocks?
Via The Motley Fool
S&P 500, Nasdaq 100 Hit Record Highs As Dollar, Treasury Yields Weaken, Chipmakers Shine, NYCB Sinks: What's Driving Markets Friday?
Via Benzinga
Topics Economy Stocks
Exposures Interest Rates US Equities
Why Ginkgo Bioworks Stock Is Down After Earnings
Via Benzinga
Hewlett Packard Enterprise Posts Mixed Q1 Results, Joins Fisker, Plug Power And Other Big Stocks Moving Lower In Friday's Pre-Market Session
Via Benzinga
Topics Stocks
Exposures US Equities
Why Zscaler Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
bit.bio Announced as Inaugural Partner of Ginkgo Bioworks’ New Technology Network
From bit.bio
Via Business Wire
2 Top Biotech Stocks That Wall Street Thinks Could Soon Double in Value
Via The Motley Fool
7 Stocks Cathie Wood Is Still Loading Up On in Q1
Via InvestorPlace
2 Cathie Wood Stocks With Jaw-Dropping Growth Potential
Via The Motley Fool
Cathie Wood Just Bought These 3 Biotech Stocks. Should You?
Via The Motley Fool
Not Shy Of Buying The Dip, Cathie Wood's Ark Mops Up Over $11M Worth Of Shares In Tesla — Sells Nvidia Stock
Via Benzinga
Cathie Wood's Ark Loads Up On $3.3M Worth Of Robinhood Shares, Continues Its Tesla Stock Purchase Spree
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.